GeneDx Holdings Corp.
WGS
$56.33
$4.538.75%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -101.70% | 59.80% | 102.49% | 101.20% | 71.43% |
| Total Depreciation and Amortization | 18.49% | 15.54% | 44.76% | 20.52% | -9.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 194.61% | 65.83% | -9.84% | -59.34% | 241.64% |
| Change in Net Operating Assets | -207.13% | 36.97% | 6.82% | 22.71% | 66.39% |
| Cash from Operations | -389.79% | 216.78% | 160.15% | 114.16% | 98.65% |
| Capital Expenditure | -73.04% | -246.33% | -267.86% | -184.71% | -96.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 41.22% | 60.86% | 99.84% | 82.70% | -2.05% |
| Cash from Investing | -71.77% | -104.16% | -47.82% | -0.34% | 4.80% |
| Total Debt Issued | 598.13% | -- | -71.38% | -71.38% | -71.38% |
| Total Debt Repaid | -1,579.18% | -13.55% | -42.57% | -18.81% | -21.94% |
| Issuance of Common Stock | -21.84% | -20.25% | 212.82% | 27,211.11% | 532.37% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 25.00% | 8.75% | -7.28% | 30.18% | 9.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -136.04% | 236.78% | 229.49% | 117.96% | 112.31% |